Nitrogen mustard (NM)-induced lung injury is associated with an accumulation of proinflammatory/cytotoxic M1 and antiinflammatory/wound repair M2 macrophages, which have been implicated in tissue injury and repair. Herein, we analyzed the effects of valproic acid (VPA), a histone deacetylase (HDAC) inhibitor with antiinflammatory and antioxidant activity, on lung macrophages responding to NM. Treatment of rats with NM (0.125 mg/kg, i.t.) resulted in structural alterations in the lung and a macrophage-rich inflammatory cell infiltrate, at 3 d and 7 d. This was accompanied by expression of PCNA, a marker of proliferation, and CYPb5, HO-1, and MnSOD, markers of oxidative stress. Administration of VPA (300 mg/kg/day; i.p.), beginning 30 min after NM, reduced increases in PCNA, CYPb5, HO-1, and MnSOD. This was associated with increases in immature CD11b þ CD43 þ M1 macrophages in the lung, and decreases in mature CD11b þ CD43 À M2 macrophages 3 d post NM, suggesting delayed maturation and phenotypic switching. VPA also attenuated NM-induced increases in lung iNOS þ and CCR2 þ M1 macrophages, a response correlated with downregulation of NOS2, IL12B, PTGS2, MMP-9, and CCR2 expression. Conversely, numbers of CD68 þ , CD163 þ , and ATR-1a þ M2 macrophages increased after VPA, along with the expression of IL10, ApoE, and ATR-1A. NM exposure resulted in increased HDAC activity and upregulation of HDAC2 and acetylated H3K9 in the lung. Whereas VPA blunted the effects of NM on HDAC2 expression, histone H3K9 acetylation increased. These data suggest that alterations in the balance between histone acetylases and deacetylases contribute to lung macrophage maturation and activation following NM exposure.
Nitrogen mustard (NM) is a bifunctional alkylating agent known to cause acute lung injury characterized by hemorrhage, edema, and inflammation. This progresses to bronchiolitis, emphysema and fibrosis (Malaviya et al., 2012 Sunil et al., 2011) . These pathologic responses are a consequence of oxidative and nitrosative damage, epithelial necrosis, and vascular disruption (Weinberger et al., 2016) . In earlier studies, we showed that NMinduced injury and fibrosis are associated with a persistent increase in macrophages in the lung (Malaviya et al., 2012; Venosa et al., 2016) . These cells were found to consist of two distinct subpopulations that sequentially accumulate in the lung: proinflammatory/cytotoxic M1 macrophages and antiinflammatory/wound repair M2 macrophages. Whereas overactive M1 macrophages promote redox stress and aggravate lung injury, hyper-responsive M2 macrophages contribute to the development of fibrosis Martinez and Gordon, 2014) .
Macrophage activity is controlled, in part, by epigenetic alterations in the DNA including post-translational modifications of histone proteins, which lead to changes in gene expression and phenotype (Jaenisch and Bird, 2003; Shanmugam and Sethi, 2013) . Of particular interest is the acetylated state of histones, which has emerged as an important regulator of macrophage activation (Ivashkiv, 2013) . Whereas acetylation of lysine (K) residues 9, 14, or 27 on histone 3 (H3K9, H3K14, or H3K27) by histone acetylases (HAT)s is associated with transcriptional activation of inflammatory genes and the development of an M1 macrophage phenotype, deacetylation of these lysine residues by histone deacetylases (HDAC)s correlates with transcriptional repression, downregulation of inflammatory genes, and M2 macrophage activation (Chandran et al., 2015; Mullican et al., 2011) . Evidence suggests that macrophage gene expression during acute and chronic inflammatory responses resulting in M1 or M2 phenotypic activation is controlled by the relative activity of HATs and HDACs (Ishii et al., 2009; Ivashkiv, 2013; Kittan et al., 2013) .
Valproic acid (VPA) is a short-chain aliphatic organic acid used clinically as a mood stabilizer and antidepressant, and for treatment of migraine headaches (Ueda and Willmore, 2000) . Recent studies have shown that VPA also exerts antiinflammatory and antioxidant activity, which is thought to be due to its ability to inhibit HDACs, preventing deacetylation of nonhistone proteins important in macrophage activation (Cavasin et al., 2012; Rahman et al., 2004; Wu et al., 2015) . Thus, in models of acute lung injury, pulmonary hypertension, allergic airway disease and sepsis, VPA is effective in blunting production of proinflammatory cytokines, oxidative stress, and tissue injury (Cetinkaya et Royce et al., 2011; Shang et al., 2010; Wu et al., 2012 Wu et al., , 2015 . The fact that inflammation and oxidative stress are important contributors to NM-induced lung disease pathogenesis prompted us to assess the ability of VPA to mitigate these responses. Our findings that VPA suppressed NM-induced oxidative stress, lung cell proliferation, and proinflammatory/ cytotoxic M1 macrophage maturation and activation, while promoting antiinflammatory/wound repair M2 macrophage activation, suggest that histone acetylase/deacetylase balance is important in regulating inflammatory responses in the lung during the pathogenic response to NM. BAL was collected by slowly instilling and withdrawing 10 ml of ice cold (4 C) PBS into the lung through a cannula inserted into the trachea. BAL was centrifuged (300Âg, 8 min) and cell pellets resuspended in 1 ml of PBS for differential analysis and viable cell counting using a hemocytometer with trypan blue dye exclusion. Cell-free supernatants were assayed for protein content using a BCA protein assay kit (Pierce Biotechnologies Inc., Rockford, IL) with bovine serum albumin as the standard. In some experiments, following BAL collection, the lung was removed and 10 ml of ice cold PBS slowly instilled and withdrawn through the cannula, while gently massaging the tissue; this procedure was repeated four times. The lavage fluid was combined with the initial BAL cell suspension, centrifuged (300Âg, 8 min), resuspended in 10 ml PBS and the cells enumerated. Differential staining demonstrated that 86%-94% of BAL cells were macrophages. were immunostained with antibody to PCNA. Binding was visualized using a Vectastain kit. Original magnification, Â200 (upper panels) and Â600 (lower panels).
MATERIALS AND METHODS
Representative sections from 3 to 4 rats/treatment group are shown.
Histology and immunohistochemistry. Following BAL collection, the lung was removed, fixed with 2% paraformaldehyde and paraffinembedded. For histological analysis, sections (5 lm) were stained with hematoxylin and eosin. Histopathological changes were assessed blindly by a veterinary pathologist (LeRoy Hall, DVM, PhD) as previously described (Malaviya et al., 2010) . Semiquantitative grades (0-4) were assigned to histological sections, with grade 0 indicating no changes; grade 1, minimal or small changes; grade 2, medium changes, grade 3, moderate changes, and grade 4, extensive changes, relative to PBS controls. For immunostaining, sections were deparaffinized with xylene followed by decreasing concentrations of ethanol (100%-50%) and then water. After antigen retrieval using citrate buffer (10.2 mM sodium citrate, 0.05% Tween 20, pH 6.0, 10 min) and quenching of endogenous peroxidase with 3% hydrogen peroxide in methanol (30 min), sections were incubated for 2 h at room temperature with 10% serum to block nonspecific binding. This was followed by overnight incubation at 4 C in a humidified chamber with rabbit monoclonal anti-CD11b (1:500, Abcam, Cambridge, MA), anti-inducible nitric oxide synthase (iNOS, 1:800, Abcam, Cambridge, Massachusetts), mouse monoclonal anti-CD68 (1:400, AbD Serotec., Raleigh, NC), mouse monoclonal anti-CD163 (1:400, AbD Serotec), rabbit polyclonal anti-histone deacetylase 2 (HDAC2, 1:150, Santa Cruz Biotechnologies, Dallas, Texas), rabbit monoclonal anti-acetylated H3K9 (H3K9Ac, 1:350, Cell Signaling Technology, Danvers, Massachusetts), rabbit monoclonal anti-CCR2 (1:400, Abcam), rabbit polyclonal anti-angiotensin-2 receptor 1a (ATR-1a, 1:500, Abcam), rabbit monoclonal anti-cytochrome b5 (CYPb5, 1:1500, Abcam), rabbit polyclonal anti-heme oxygenase-1 (HO-1, 1:250, Enzo Life Sciences, Farmingdale, NY), rabbit polyclonal anti-manganese superoxide dismutase (MnSOD, 1:150, Enzo Life Sciences), or rabbit polyclonal anti-proliferating cell nuclear antigen (PCNA, 1:800, Abcam) antibody, or the appropriate serum/IgG controls diluted in blocking buffer. Sections were then washed and incubated at room temperature for 30 min with biotinylated secondary antibody (Vectastain Elite ABC kit, Vector Labs, Burlingame, CA). Binding was visualized using a Peroxidase Substrate Kit DAB (Vectastain). In previous studies, we demonstrated that lavaging the lung prior to histologic sectioning had no significant effect on the architecture of the lung or on macrophages present in the tissue . mRNA isolation and PCR analysis. Total mRNA was extracted from lung cells collected by BAL and tissue massage using an RNeasy Mini kit (Qiagen, Valencia, CA). RNA was reverse transcribed using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA). Standard curves were generated using serial dilutions from pooled cDNA samples. Real time PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems) on an Applied Biosystems 7300HT thermal cycler. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used to normalize the data. Full-length coding sequences were obtained from the NCBI Gene Bank. Primers were designed using Primer Express 3.0 software (Applied Biosystems). The following forward and reverse primers were used: GAPDH, CCTGGAG AAACCTGCCAAGTAT and CTCGGCCGCCTGCTT; nitric oxide synthase (NOS)2, TGGTGAAAGCGGTGTTCTTTG and ACGCGGGAAG CCATGA; prostaglandin-endoperoxide synthase (PTGS2), TGCTC ACTTTGTTGAGTAGTCATTCAC and CATTCCTTCCCCCAGCAA; interleukin (IL)12B, GCACACTGGAGGCCTGCTT and TTAGTAGCC AGGCAACTCTCATTCT; matrix metalloproteinase-9 (MMP-9), ATTCTCGGTGGACCAATGACGTG and AATGTCCATGTTAACGGG; IL10, CCCAGAAATCAAGGAGCATTTG and CAGCTGTATCCAGA GGGTCTTCA; apolipoproteinE (ApoE), TCCATTGCCTCCACCACAGT and GGCGTAGGTGAGGGATGATC; angiotensin receptor (ATR)-1A, CCATTGTCCACCCGATGAA and TGACTTTGGCCACCAGCAT; CCR2, TGACAGAGACTCTTGGAATGACACA and CTCACCAACAAAGGCA TAAATGAT; CCL2, CCACTCACCTGCTGCTACTCAT and TCTCCA GCCGACTCATTGG; CX 3 CR1, GGAGCAGGCAGGACAGCAT and CCCTCTCCCTCGCTTGTGTA. Measurement of HDAC activity. HDAC activity was analyzed in nuclear extracts (4 lg), prepared from lung macrophages collected by BAL and massage, using a colorimentric EpiQuick HDAC assay kit according to the manufacturer's protocol (Epigentek Group Inc., Farmingdale, New York). The assay was performed three times in triplicate.
Statistical analysis. Flow cytometry, BAL cell, BAL protein, and PCR data were analyzed using Kruskal-Wallis non-parametric one-way ANOVA followed by the Mann-Whitney post-hoc test. Histological scoring data were analyzed using Kruskal-Wallis non-parametric one-way ANOVA followed by Mann-Whitney Rank Sum post-hoc test. HDAC activity data were analyzed by one-way ANOVA followed by unpaired t-test. All experiments were repeated at least three times. A P value of .05 was considered statistically significant.
RESULTS
VPA reduces NM-induced cellular proliferation, inflammation, and oxidative stress Consistent with previous reports (Malaviya et al., 2012; Sunil et al., 2014; Venosa, et al., 2016) , NM was found to induce significant histopathological changes in the lung. Thus, within 3 d of exposure, perivascular edema and hemorrhage were noted, along with an accumulation of cellular debris ( Figure 1 and Table 1 ). This was associated with a marked infiltration of inflammatory cells, which were comprised predominantly of macrophages (Malaviya et al., 2012; Venosa et al., 2016) ; these persisted in the tissue for at least 7 d. At 7 d post-NM, bronchial epithelial cell and goblet cell hyperplasia, alveolar septal thickening, bronchiolization of the alveolar epithelium, and loss of alveolar architecture were also observed. These structural alterations were associated with proliferation of macrophages, as well as epithelial cells, as measured by PCNA staining, which was evident at 3 d and 7 d post-NM ( Figure 2 and Table 2 ). NM exposure also resulted in increases in BAL protein and cell content, indicative of alveolar epithelial barrier disruption and lung inflammation (Bhalla, 1999) (Figure 3) . Expression of CYPb5, HO-1, and MnSOD, markers of oxidative stress (Kinnula et al., 2005; Menoret et al., 2012) , was also increased after NM exposure, most notably at 3 d (Figure 4 , Table 2 and Supplementary  Figure 1) . Treatment of rats with VPA beginning 30 min after NM was found to dampen the effects of NM on PCNA expression, most prominently at 7 d (Figure 2 and Table 2 ). NM-induced increases in BAL cell content and expression of HO-1, MnSOD and CYPb5 expression were also reduced by VPA at 3 d post-NM (Figs. 3 and 4, Table 2 , and Supplementary Figure 1) . In contrast, VPA had no effect on NM-induced increases in BAL protein levels or on structural alterations in the lung.
VPA promotes a persistent increase in immature macrophages in the lung
The effects of VPA on the phenotype of macrophages accumulating in the lung in response to NM were next analyzed using techniques in flow cytometry. In accord with our previous findings (Venosa et al., 2015) , NM exposure resulted in an increase in CD11b þ migrating inflammatory macrophages in the lung equivalent numbers of CD43 À macrophages were noted in lungs of vehicle-and VPA-treated rats. Resident CD11b À CD43 À macrophages were also identified in the lung; these cells decreased after NM; however, they were largely unaffected by VPA ( Figure 5 ).
VPA dampens NM-induced proinflammatory macrophage activation
In further studies, we assessed the effects of VPA on expression of markers of inflammatory macrophage phenotype and activation in histologic sections. Consistent with our flow cytometric findings, following NM administration, a persistent increase in CD11b þ migrating inflammatory macrophages was observed in the lung; VPA had no effect on these cells ( Figure 6 and Table 2 ). Conversely, VPA caused a reduction in lung macrophages expressing the proinflammatory M1 marker, iNOS at both 3 d and 7 d ( Figure 6 , Table 2 , and Supplementary Figure 2) . A decrease in CCR2 þ M1 macrophages was also observed 3 d post-NM exposure in VPA-treated rats. Decreases in iNOS þ and CCR2 þ macrophages responding to NM were correlated with reduced expression of macrophage proinflammatory genes including NOS2, PTGS2, IL12B, MMP-9, CCR2, and CCL2 (Figure 7) . Following NM administration, we also noted increased numbers of CD68 þ , CD163 þ , and ATR-1a Table  2 , and Supplementary Figure 3) . This was accompanied by increases in expression of IL10, ApoE, and ATR-1A (Figure 7) . Conversely, after VPA administration, NM-induced increases in CX 3 CR1 expression were reduced at 7 d post-exposure.
VPA inhibits NM-induced upregulation of HDAC2
Treatment of rats with NM resulted in an increase in macrophage HDAC activity at 3 d post-exposure; by 7 d, levels, HDAC activity was at control levels ( Table 3) . Expression of HDAC2 and acetylated histone H3K9 was also upregulated in macrophages, as well as epithelial cells, following NM exposure, a response most prominent at 3 d ( Figure 9 and Supplementary Figure 3) . Whereas VPA blunted the effects of NM on expression of HDAC2, the expression of acetylated H3K9 increased ( Figure 9 and Table 2 ).
DISCUSSION
Macrophages are sentinels of the innate immune system in the lung; they have also emerged as key inflammatory cells contributing to both protective and pathologic responses to pulmonary injury. To execute these divergent activities, they develop into distinct subpopulations broadly classified as proinflammatory/ cytotoxic M1 and anti-inflammatory/wound repair M2 macrophages. The present studies demonstrate that macrophage activation in the lung in response to NM-induced injury is regulated, at least in part, by HDACs. This is based on our findings that after administration of the HDAC inhibitor VPA, activated iNOS þ and CCR2 þ proinflammatory M1 macrophages, were decreased in the lungs of NM-treated rats, along with macrophage proinflammatory gene expression, while anti-inflammatory/wound repair CD68
, and ATR-1a þ M2 macrophages and macrophage anti-inflammatory gene expression were increased. The fact that this was correlated with a reduction in NM-induced oxidative stress, inflammation and cellular proliferation provide support for a role of inflammatory macrophages in the pathogenic response to NM, and offer novel insights into mechanisms regulating lung macrophage activation. A characteristic response to acute tissue injury is cellular proliferation and upregulation of PCNA (Bardales et al., 1996) . This reparative hyperplasia, which is observed in epithelial cells, fibroblasts and other mesenchymal cells, typically develops 3-7 days after injury. In line with these reports and our previous studies (Malaviya et al., 2012; Sunil et al., 2014) , we found that acute lung injury and hyperplasia induced by NM were associated with increased PCNA expression in epithelial cells, as well as macrophages. This most likely reflects an early attempt to replace cells damaged by NM. We also found that markers of oxidative stress including CYPb5, HO-1, and MnSOD were upregulated after NM. These findings are in accord with reports that NM-induced tissue injury involves oxidative stress FIG. 7 . Effects of VPA on NM-induced pro-and anti-inflammatory gene expression in lung macrophages. Cells, collected by BAL and massage 3 d and 7 d after exposure of rats to PBS (CTL) or NM, followed by vehicle (Veh) or VPA, were analyzed by RT-PCR. Data were normalized relative to GAPDH and analyzed using Kruskal-Wallis non-parametric one-way ANOVA followed by the MannWhitney post-hoc test. Bars, mean 6 SE (CTL/Veh, n ¼ 3; NM 3 d/Veh, n¼ 5, NM 7 d/Veh, n¼ 5, CTL/VPA, n¼ 6, NM 3 d/VPA, n ¼ 5, NM 7 d/VPA, n ¼ 5). *Significantly different (P .05) from CTL. #Significantly different (P .05) from Veh. (Kinnula et al., 2005) . VPA was found to attenuate the effects of NM on cellular proliferation and oxidative stress. This is consistent with the observation that VPA exerts antioxidant and antiproliferative activity in experimental models of lung injury induced by hyperoxia and ischemia-reperfusion (Cetinkaya, et al., 2015; Costalonga et al., 2016; Wu et al., 2015) . VPA has been reported to modulate the expression of genes associated with cell cycle arrest, apoptosis, and DNA repair, as well as oxidative stress (Rucker et al., 2016; Strzalka and Ziemienowicz, 2011) ; this may contribute to its suppressive effects on NM-induced PCNA and antioxidant expression in the lung. By comparison, VPA had no effect on NM-induced alveolar epithelial barrier dysfunction, as measured by BAL protein levels, or on structural alterations in the respiratory tract. These findings suggest that there are multiple mechanisms underlying the pathologic and cytotoxic effects of NM in the lung (Weinberger et al., 2016) . Previous studies demonstrated that VPA was effective in reducing acute lung injury induced by LPS, ischemia-perfusion and sepsis (Ji et al., 2013; Kim et al., 2012; Shang, et al., 2010; Wu et al., 2015) . It may be that lung injury induced by NM is more severe and that longer treatment times or additional therapeutics with antioxidant and/or anti-inflammatory activity are required to mitigate its toxicity.
In earlier studies, we demonstrated that immature CD11b
þ macrophages responding to NM exhibit an M1-like phenotype, while mature CD11b
Effects of VPA on NM-induced increases in anti-inflammatory macrophages accumulating in the lung. Sections, prepared 3 d and 7 d after exposure of rats to PBS (CTL) or NM, followed by vehicle (Veh) or VPA, were immunostained with antibodies to CD68, CD163, or ATR-1a. Binding was visualized using a Vectastain kit.
Original magnification, Â600. Representative sections from 3 to 4 rats/treatment group are shown. exhibit an M2-like phenotype; moreover, increases in M2 macrophages in the lung following NM exposure are due, in part, to phenotypic switching of M1 macrophages (Venosa et al., 2015 . The present studies show that after VPA administration, there is a change in these macrophage subpopulations in the lungs of NM treated rats; thus, at 3 d post-NM, immature CD11b þ CD43 þ macrophages were increased relative to vehicle treated rats, while mature CD11b þ CD43 À macrophages were decreased. Additionally, immature cells remained elevated in the lung for at least 7 d; at this time, comparable numbers of mature cells were observed in the lungs of vehicle and VPAtreated rats. HDAC inhibitors have been shown to suppress macrophage maturation from monocytic precursors (Nencioni et al., 2007; Rosborough et al., 2012; Sebastian et al., 2008) . In contrast to our findings with CD11b þ CD43 þ M1 macrophages isolated from the lung, NM-induced increases in iNOS þ and CCR2 þ M1 macrophages in histologic sections were blunted following VPA administration. These data suggest that there are multiple subtypes of M1 macrophages responding to NM induced lung injury, which is in accord with previous findings in other models of inflammatory disease (Lech and Anders, 2013; Martinez et al., 2008) . It is possible that iNOS þ and CCR2 þ M1 macrophages are more mature and functionally activated, when compared with CD11b þ CD43 þ M1 macrophages and thus, more sensitive to VPA, however, this remains to be evaluated. VPA-induced decreases in iNOS þ and CCR2 þ lung macrophages were correlated with reduced expression of NOS2, PTGS2, IL12B, MMP-9, CCR2, and CCL2, proinflammatory genes known to be expressed by activated M1 macrophages (Mantovani et al., 2004) . These findings are consistent with reports that HDACs positively regulate expression of proinflammatory genes and M1 macrophage activation (Aung et al., 2006; Brogdon, et al., 2007; Leoni et al., 2002; Shakespear et al., 2013) . Similar decreases in proinflammatory gene expression and M1 macrophages have been described in experimental models of acute lung injury, sepsis, ischemia-reperfusion injury, and rheumatoid arthritis after administration of HDAC inhibitors, including VPA (Brogdon et al., 2007; Cetinkaya et al., 2015; Fukudome et al., 2012; Grabiec et al., 2010; Kim et al., 2012; Ni et al., 2010; Shang et al., 2010) . M1 activation of macrophages and proinflammatory gene expression are regulated, in part, by the transcription factor NF-jB. In macrophages, upregulation of HDAC1 and HDAC3 results in NF-jB activation (Park et al., 2007; Rahman et al., 2004) . HDAC inhibitors are thought to suppress inflammation by targeting transcription of inflammatory genes or processes upstream of their transcription (Bode et al., 2007; Ichiyama et al., 2000; Schwertheim et al., 2014) . This is supported by findings that VPA blocks the NFjB inhibitory protein, IjK, by preventing its deacetylation resulting in decreased NFjB translocation to the nucleus and its ability to upregulate inflammatory gene expression . Suppression of NFjB activation has also been described after VPA treatment as a consequence of inhibition of glycogen synthase kinase-3 (Kostrouchova et al., 2007) . Further studies are required to determine if VPA similarly blocks NFjB activation following NM administration, and if this contributes to decreases in M1 macrophages in the lung. Compared with its suppressive effects on M1 macrophages, VPA caused an expansion of CD68 negatively regulates M2 macrophage activation (Mullican et al., 2011) and that HDAC inhibition results in M1 to M2 phenotypic switching (Kapellos and Iqbal, 2016; Leoni et al., 2002; Park et al., 2007; Wang et al., 2015; Wu et al., 2012) . Our observation that there are increases in CD163 þ , CD68 þ , and ATR1a þ antiinflammatory/wound repair M2 macrophages in the lung 3 d post-NM exposure suggest that inflammatory resolution is initiated more rapidly following VPA treatment. This is supported by our findings that VPA blunted the effects of NM on BAL cell number. Our results also suggest that M2 macrophage subpopulations identified in histologic sections are distinct from CD11b þ CD43 À M2 macrophages, which is in accord with reports that there are multiple subpopulations of M2 macrophages that vary in phenotype and function (Mantovani et al., 2004; Mosser and Edwards, 2008) . This may also reflect differences in the response of alveolar macrophages recovered by lavage and massage, when compared with tissue-associated macrophage identified in histologic sections. Acetylation of H3K9 is considered a marker of increased proinflammatory gene expression and macrophage activation (Grabiec et al., 2010; Ivashkiv, 2013) . Consistent with this notion, we found that NM-induced upregulation of proinflammatory gene expression in the lung was associated with increased expression of acetylated H3K9. Expression of HDAC2 and the activity of HDAC, which exerts strong catalytic actions on acetylated histone H3 (Rafehi et al., 2014) , were also increased in lung macrophages after NM. This may reflect a compensatory response aimed at limiting inflammatory gene expression. The fact that HDAC2 and H3K9Ac expression were upregulated in epithelial cells after NM exposure suggests that histone remodeling also occurs in these cells in response to tissue injury. This may be important in their release of chemokines and other proinflammatory mediators that contribute to the recruitment and activation of macrophages in the lung. VPA administration resulted in reduced HDAC2 expression, a response correlated with increased histone H3K9 acetylation at 3 d. These findings provide support for the idea that VPA alters chromatin remodeling in macrophages (Wu et al., 2012) and confirm that HDAC2 is a target for VPA (Hezroni et al., 2011; Ropero et al., 2006) .
VPA and other short-chain branched fatty acids have emerged as potent anti-inflammatories and antioxidants (Ximenes et al., 2013) . Although the precise mechanisms underlying these actions have not been clearly established, inhibition of HDACs appears to be involved. The relative activity of HATs and HDACs has been shown to play a key role in macrophage phenotypic activation in response to inflammatory signals (Ivashkiv, 2013) . The present studies demonstrate that VPA-induced inhibition of HDAC results in a change in the balance between pro-and anti-inflammatory macrophages in the lung after NM exposure. Previous studies have demonstrated that HDAC inhibition using trichostatin-A reduces the acute pulmonary toxicity of NM (Korkmaz et al., 2008) . Together, these findings support the idea that decreases in NMinduced oxidative stress and cellular proliferation following VPA administration are due to alterations in acetylation of proteins that regulate macrophage inflammatory activity. Elucidation of epigenetic mechanisms mediating macrophage phenotypic activation represents an important step in understanding the role of these cells in NM-induced lung injury and may lead to the development of therapeutic interventions targeting these pathways.
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